Revium Recovery Inc
Revium Rx. operates as a pre-clinical stage biopharmaceutical company focused on the development of nanoparticle-based therapies in the United States. The company develops lipid-based platforms for a variety of uses including antimicrobial resistance and solid tumors. The company specializes in infectious diseases, including antibiotic-resistant infections, solid tumors and vaccination. The compa… Read more
Revium Recovery Inc (RVRC) - Total Liabilities
Latest total liabilities as of June 2025: $645.00K USD
Based on the latest financial reports, Revium Recovery Inc (RVRC) has total liabilities worth $645.00K USD as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Revium Recovery Inc - Total Liabilities Trend (2018–2024)
This chart illustrates how Revium Recovery Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Revium Recovery Inc Competitors by Total Liabilities
The table below lists competitors of Revium Recovery Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Metro Systems Corporation Public Company Limited
BK:MSC
|
Thailand | ฿1.91 Billion |
|
Banimmo S.A.
LSE:0NG8
|
UK | €107.11 Million |
|
Nupur Recyclers Limited
NSE:NRL
|
India | ₹332.18 Million |
|
Shalimar Paints Limited
NSE:SHALPAINTS
|
India | ₹4.03 Billion |
|
Pacific Orient Bhd
KLSE:6009
|
Malaysia | RM784.00 Million |
|
The Practical Solution Public Company Limited
BK:TPS
|
Thailand | ฿533.28 Million |
|
Nosa Med AB
ST:NOSA
|
Sweden | Skr25.36 Million |
Liability Composition Analysis (2018–2024)
This chart breaks down Revium Recovery Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 6.93 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.03 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.03 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Revium Recovery Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Revium Recovery Inc (2018–2024)
The table below shows the annual total liabilities of Revium Recovery Inc from 2018 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $360.00K | +150.00% |
| 2023-12-31 | $144.00K | +105.71% |
| 2022-12-31 | $70.00K | +9.38% |
| 2021-12-31 | $64.00K | -81.97% |
| 2020-12-31 | $355.00K | +4688.88% |
| 2018-12-31 | $7.41K | -- |